你即將離開本站

並前往https://news.bms.com/news/corporate-financial/2021/Bristol-Myers-Squibb-Research-at-ESMO-2021-Demonstrates-Clinical-Benefits-of-Immunotherapies-in-Multiple-Hard-to-Treat-Advanced-or-Metastatic-Cancers-and-Reinforces-the-Benefit-of-Opdivo-in-Earlier-Stage-Cancers/default.aspx

Bristol Myers Squibb Research at ESMO 2021 Demonstrates ...

Bristol Myers Squibb Research at ESMO 2021 Demonstrates Clinical Benefits of Immunotherapies in Multiple Hard-to-Treat Advanced or Metastatic ...

確定！ 回上一頁

查詢 「ESMO 2021」的人也找了：

  1. esmo 2022
    2.
  2. ESMO 2020
    3.
  3. esmo 2023
    4.
  4. Capdevila j et al presented at esmo 2021 abstract lba67
    5.
  5. asco 2021
    6.
  6. ESMO Asia 2023
    7.
  7. ESMO 2022 program
    8.
  8. ESMO 2022 Congress
    9.